Viewing nowPoglizin Tablet 5 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 202300407 · Approved 2023.01.31 · Insurance code 663608710
Improves blood glucose control in type 2 diabetes mellitus; prevents worsening of chronic heart failure and chronic kidney disease
This medication is used to help control blood sugar in patients with type 2 diabetes, along with diet and exercise. It is also used in patients with chronic heart failure to reduce the risk of death and hospitalization due to cardiovascular disease, in combination with other standard treatments for heart failure. In patients with chronic kidney disease, this medication helps to slow the decline in kidney function and reduce the risk of death related to cardiovascular disease. Thus, this medication is effectively used in the treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no relevant data.
This medication should not be used in patients who are allergic to the active ingredient or other excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance, certain genetic issues, and those undergoing dialysis should also refrain from using this medication. It should be used cautiously in patients with low fluid volume or poor kidney function. This medication may cause side effects such as low blood pressure or changes in kidney function, so these patients should be carefully monitored before and after administration. In patients with significantly impaired kidney function, blood sugar control effectiveness may decrease, necessitating careful attention. Side effects like genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis may occur when taking this medication. Especially women, or patients with a history of previous infections, are at higher risk of infections. There may be a risk of hypoglycemia, so dose adjustments may be needed when used with insulin or sulfonylureas. Pregnant or breastfeeding women are advised not to use this medication, and it should be discontinued immediately if pregnancy is confirmed. Elderly patients or those taking multiple medications should be cautious regarding drug interactions and changes in kidney function. This medication can increase urine output, potentially causing reduced fluid volume or low blood pressure, so fluid status should be checked frequently. In case of overdose, there is no specific antidote, and appropriate treatment should be provided based on symptoms. Finally, during the course of taking this medication, blood sugar and ketone levels should be monitored regularly, and any unusual symptoms should lead to immediate consultation with a healthcare professional.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, reduced creatinine clearance in the early treatment phase, dyslipidemia, elevated blood creatinine in the early treatment phase, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral arterial occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorder, syncope, tremor, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like symptoms, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcers, sweating abnormalities eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, hives, cold sweat, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, muscle weakness, contusion, road traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, iliac fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibia fracture, dental injury, dry eye, ocular pain, retinal disorders, visual acuity reduction, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid swelling, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorder, epistaxis, obstructive sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, enuresis, auditory hallucinations, insomnia, fatty liver, gallbladder polyp, tinnitus, anal genital warts, glandular adenoma, neuroma, unspecified pituitary neoplasm, male gonadal hypofunction, thyroid cyst, thyroid mass, food allergy, erythrocytosis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and safety.
Yellow, biconvex, round film-coated tablets
28 tablets/box [(14 tablets/PTP×2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.